TOTAL VOLUME:

$154.4b

24H VOL:

$230,589,906

24H TRANSACTIONS:

2,984,028,936

OPEN INTEREST:

$1,885,293,300

410,482

Markets across

40,213

events

MATCHED EVENTS:

4,340

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Insights
Indices
API
Tour
All
Trending
Breaking
New
Ending Soon
Politics
Sports
Elections
Crypto
Companies
Financials
Economics
Other
Entertainment
Science and Technology
Will Cigna (CI) beat quarterly earnings?
polymarket

Will Cigna (CI) beat quarterly earnings?

Oct 26, 2026, 8:03 PM EST - Nov 5, 2026, 9:00 AM EST
Total volume:
$1,353
Volume 24h:
$611
994%
Liquidity:
$348
57%
Open interest:
$442N/A

Will Cigna (CI) beat quarterly earnings?

 - Polymarket

Will Cigna (CI) beat quarterly earnings? - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Nov 5, 2026

Time left: 02d:14h:59m

Will Cigna (CI) beat quarterly earnings?

40%chance
Amount

$

Trade on
polymarket

Trade on Polymarket

At 41¢ buys you 244 shares | Odds: 40% Total Payout: $244 | Net Profit: $144 Multiplier: 2.44x | ROI: 144% APY not meaningful Low liquidity 2 days to resolution
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
polymarket

Will Cigna (CI) beat quarterly earnings?

Trade
40%
Yes 41¢No 62¢
3¢
$348
$1,353
82%
N/A
N/A
2d 14h 59m
Active
Total markets: 1

Description

As of market creation, Cigna is estimated to release earnings on November 5, 2026. The Street consensus estimate for Cigna’s non-GAAP EPS for the relevant quarter is $7.73 as of market creation. This market will resolve to "Yes" if Cigna reports non-GAAP EPS greater than $7.73 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Cigna releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Polymarket

As of market creation, Cigna is estimated to release earnings on November 5, 2026. The Street consensus estimate for Cigna’s non-GAAP EPS for the relevant quarter is $7.73 as of market creation. This market will resolve to "Yes" if Cigna reports non-GAAP EPS greater than $7.73 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Cigna releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Frequently asked questions

On Polymarket, the dashboard for the Cigna earnings market tracks the current odds of Cigna beating quarterly earnings, the price history of the market, and the 24-hour trading volume. Currently, the volume is $611. Traders use this information to assess market sentiment and make informed decisions. The dashboard also displays the total volume traded to date, which is $1,353. This allows participants to understand the overall interest and activity surrounding this particular market.

Currently, the implied probability of Cigna beating quarterly earnings, as reflected by this market, is 39.5%. This differs from traditional analyst forecasts, which often rely on modeling and expert opinions. While analyst expectations are widely publicized, this market represents a collective forecast from a diverse group of traders who are incentivized to be accurate. Discrepancies between the two can highlight areas where the market anticipates information not yet fully incorporated into standard financial analysis. It's a different way to gauge expectations for Cigna's performance.

On Polymarket, this market is priced through a continuous auction mechanism where traders buy and sell shares representing their belief about whether Cigna will beat quarterly earnings. The price of these shares fluctuates based on supply and demand, reflecting the collective wisdom of the crowd. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The closer the earnings announcement date, the more the price will likely move as new information becomes available and traders adjust their positions. This dynamic pricing allows for a real-time assessment of expectations.

This market resolves around Nov 5, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will be based on whether Cigna’s reported earnings per share (EPS) exceed the consensus estimate of financial analysts covering the company. The final price of shares in this market will reflect whether Cigna successfully surpassed those expectations. Traders will then be able to claim their winnings or account for any losses based on their positions at resolution.

Several signals could significantly move this market before it resolves. Any news related to Cigna’s financial health, such as pre-earnings announcements, changes in guidance, or broader economic indicators impacting the healthcare sector, could influence trading activity. Unexpected announcements from competitors or regulatory changes could also play a role. Furthermore, general market sentiment and overall investor confidence can affect the price of shares in this market. Monitoring these factors will be crucial for anyone looking to trade or analyze the Cigna earnings market.